We are live on ! Find out more

1,470 hedge funds and large institutions have $103B invested in Merck in 2013 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 568 increasing their positions, 619 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 53

36% more call options, than puts

Call options by funds: $1.25B | Put options by funds: $918M

1.31% more ownership

Funds ownership: 76.5%77.81% (+1.3%)

1% more capital invested

Capital invested by funds: $102B → $103B (+$1.23B)

1% more funds holding

Funds holding: 1,4591,470 (+11)

8% less repeat investments, than reductions

Existing positions increased: 568 | Existing positions reduced: 619

3% less funds holding in top 10

Funds holding in top 10: 120117 (-3)

Holders
1,470
Holders Change
+11
Holders Change %
+0.75%
% of All Funds
47.65%
Holding in Top 10
117
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-2.5%
% of All Funds
3.79%
New
78
Increased
568
Reduced
619
Closed
53
Calls
$1.25B
Puts
$918M
Net Calls
+$331M
Net Calls Change
-$98.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
76
Thrivent Financial for Lutherans
Minnesota
$212M +$14.1M +309,729 +7%
PPA
77
Parametric Portfolio Associates
Washington
$211M -$5.45M -119,285 -3%
Citigroup
78
Citigroup
New York
$211M -$59M -1,292,895 -22%
BGIM
79
Brandywine Global Investment Management
Pennsylvania
$210M +$5.24M +114,839 +3%
RFC
80
Russell Frank Company
Washington
$208M -$10.7M -233,741 -5%
Lazard Asset Management
81
Lazard Asset Management
New York
$207M -$22.1M -484,398 -10%
Loomis, Sayles & Company
82
Loomis, Sayles & Company
Massachusetts
$207M +$46M +1,007,137 +28%
SCCM
83
Schafer Cullen Capital Management
New York
$205M -$859K -18,812 -0.4%
MTB
84
Mizuho Trust & Banking
Japan
$193M
Adage Capital Partners
85
Adage Capital Partners
Massachusetts
$186M -$22M -481,451 -11%
BJ
86
BlackRock Japan
Japan
$183M -$25.2M -551,838 -12%
SO
87
STRS Ohio
Ohio
$176M -$17.2M -376,059 -9%
JHIU
88
Janus Henderson Investors US
Colorado
$174M -$93.5M -2,048,836 -35%
State of Wisconsin Investment Board
89
State of Wisconsin Investment Board
Wisconsin
$174M -$5.69M -124,657 -3%
Victory Capital Management
90
Victory Capital Management
Texas
$166M +$167M +3,649,766 New
TD Asset Management
91
TD Asset Management
Ontario, Canada
$165M -$674K -14,760 -0.4%
USAA
92
United Services Automobile Association
Texas
$162M -$1.39M -30,473 -0.8%
LCS
93
Levin Capital Strategies
New York
$162M +$26.9M +588,386 +20%
Swiss National Bank
94
Swiss National Bank
Switzerland
$161M +$2.67M +58,374 +2%
Principal Financial Group
95
Principal Financial Group
Iowa
$161M -$9.57M -209,602 -6%
SIM
96
Sprucegrove Investment Management
Ontario, Canada
$157M -$36M -789,563 -19%
Westfield Capital Management
97
Westfield Capital Management
Massachusetts
$155M -$6.27M -137,420 -4%
VOYA Investment Management
98
VOYA Investment Management
Georgia
$146M +$21.4M +468,993 +17%
Jennison Associates
99
Jennison Associates
New York
$137M -$1.21M -26,400 -0.9%
Brown Advisory
100
Brown Advisory
Maryland
$137M +$1.04M +22,738 +0.8%

MRK Hedge Fund Activity: Q3 2013 in Review

1,470 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2013, worth a combined $103B — up 1.2% from $102B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new MRK positions and 53 closed out — a net gain of 25 holders — while 568 added to existing stakes and 619 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $192M. The largest seller was Fidelity Investments, cutting an estimated $612M.

  • 1,470 institutional investors held Merck (MRK) as of Q3 2013, up from 1,459 in Q2 2013.
  • Funds reported $103B of Merck stock for Q3 2013, up 1.2% quarter-over-quarter.
  • 78 funds opened new Merck positions in Q3 2013 and 53 closed out, a net change of +25 holders.
  • The largest Merck buyer in Q3 2013 was Eagle Asset Management, an estimated $192M added.
  • The largest Merck seller in Q3 2013 was Fidelity Investments, an estimated $612M sold.

Based on aggregated 13F filings for Q3 2013.